Literature DB >> 18805594

MHC class II exacerbates demyelination in vivo independently of T cells.

Meenaxi M Hiremath1, Vivian S Chen, Kinuko Suzuki, Jenny P Y Ting, Glenn K Matsushima.   

Abstract

We have shown previously the importance of MHC class II for central nervous system remyelination; however, the function of MHC class II during cuprizone-induced demyelination has not been examined. Here, we show that I-A(beta)-/- mice exhibit significantly reduced inflammation and demyelination. RAG-1(1/1) mice are indistinguishable from controls, indicating T cells may not play a role. The role of MHC class II depends on an intact cytoplasmic tail that leads to the production of IL-1beta, TNF-alpha, and nitric oxide, and oligodendrocyte apoptosis. Thus, the function of MHC class II cytoplasmic tail appears to increase microglial proliferation and activation that exacerbates demyelination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805594      PMCID: PMC2913406          DOI: 10.1016/j.jneuroim.2008.06.034

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  95 in total

1.  Signaling to a CD5+ B-cell clone through surface Ig and MHC class II molecules.

Authors:  G A Bishop
Journal:  Ann N Y Acad Sci       Date:  1992-05-04       Impact factor: 5.691

2.  Signals delivered via MHC class II molecules synergize with signals delivered via TCR/CD3 to cause proliferation and cytokine gene expression in T cells.

Authors:  F Spertini; T Chatila; R S Geha
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

3.  Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1.

Authors:  P R Scholl; N Trede; T A Chatila; R S Geha
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

4.  MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.

Authors:  R König; L Y Huang; R N Germain
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

5.  Molecular events in B lymphocyte activation: consequences of signals transduced through MHC class II molecules.

Authors:  A R Baluyut; K E Pollok; S Bondada
Journal:  Cell Immunol       Date:  1993-04-01       Impact factor: 4.868

6.  Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.

Authors:  N K Damle; G Leytze; K Klussman; J A Ledbetter
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

7.  Induction of nitric oxide synthase activity by toxic shock syndrome toxin 1 in a macrophage-monocyte cell line.

Authors:  A Zembowicz; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Signal transduction mechanisms of HLA-DR-mediated interleukin-1 beta production in human monocytes. Role of protein kinase C and tyrosine kinase activation.

Authors:  T Palkama; M Hurme
Journal:  Hum Immunol       Date:  1993-04       Impact factor: 2.850

9.  Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.

Authors:  N Nabavi; G J Freeman; A Gault; D Godfrey; L M Nadler; L H Glimcher
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

10.  Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction.

Authors:  N A Flaris; T L Densmore; M C Molleston; W F Hickey
Journal:  Glia       Date:  1993-01       Impact factor: 7.452

View more
  27 in total

1.  17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Authors:  Lorelei C Taylor; Kasturi Puranam; Wendy Gilmore; Jenny P-Y Ting; Glenn K Matsushima
Journal:  Neurobiol Dis       Date:  2010-03-27       Impact factor: 5.996

2.  Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.

Authors:  Johannes Goldberg; Tim Clarner; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

3.  Primary oligodendrocyte death does not elicit anti-CNS immunity.

Authors:  Giuseppe Locatelli; Simone Wörtge; Thorsten Buch; Barbara Ingold; Friederike Frommer; Bettina Sobottka; Martin Krüger; Khalad Karram; Claudia Bühlmann; Ingo Bechmann; Frank L Heppner; Ari Waisman; Burkhard Becher
Journal:  Nat Neurosci       Date:  2012-02-26       Impact factor: 24.884

4.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

5.  Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Kai Bihler; Eugenia Kress; Stefan Esser; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Lars-Ove Brandenburg
Journal:  J Mol Neurosci       Date:  2017-05-02       Impact factor: 3.444

6.  Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.

Authors:  Hye Jung Kim; Veronique E Miron; Danuta Dukala; Richard L Proia; Samuel K Ludwin; Maria Traka; Jack P Antel; Betty Soliven
Journal:  FASEB J       Date:  2011-01-19       Impact factor: 5.191

7.  Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.

Authors:  SunJa Kim; Jacek Bielawski; Hyunmin Yang; Yu Kong; Beiyan Zhou; Jianrong Li
Journal:  Glia       Date:  2017-11-29       Impact factor: 7.452

Review 8.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

9.  A mouse model for testing remyelinating therapies.

Authors:  C Brian Bai; Sunny Sun; Andrew Roholt; Emily Benson; Dale Edberg; Satish Medicetty; Ranjan Dutta; Grahame Kidd; Wendy B Macklin; Bruce Trapp
Journal:  Exp Neurol       Date:  2016-07-03       Impact factor: 5.330

10.  Multiple sclerosis: major histocompatibility complexity and antigen presentation.

Authors:  Sreeram V Ramagopalan; George C Ebers
Journal:  Genome Med       Date:  2009-11-06       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.